IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—30 July 2013

7:27 AM MDT | July 30, 2013 | Deepti Ramesh

Lonza reports fall in profits, announces restructuring plans Lonza records a 51.2% fall in net profits for the first half of 2013 compared with the first half of 2012, to 41 million Swiss francs ($44 million). Sales for the first half of2013 decreased by 11.2%, to SF1.74 billion. Lonza also announced certain measures to restructure its activities. Lonza says that its board of directors, on 24 July, decided to phase down the company’s microbial biologics plant at Hopkinton, MA, which will lead to about 2/3 of the 300 jobs at the site being cut by the end of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa